Emami Realty Limited (NSE:EMAMIREAL)

Oncternal Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	67.3	221	150.9	92.1	123.1
Short-Term Investments	-	241.2	676.2	31.8	-	671.6
Trading Asset Securities	-	-	427.2	295.6	333	244.8
Cash & Short-Term Investments	308.5	308.5	1,324	478.3	425.1	1,040
Cash Growth	-71.88%	-76.71%	176.90%	12.52%	-59.10%	170.93%
Accounts Receivable	-	100.1	118	126.2	137.8	384.1
Other Receivables	-	-	59.3	70.1	54.5	58.1
Receivables	-	3,024	5,225	3,133	3,045	4,948
Inventory	-	10,128	9,130	8,833	8,073	8,144
Prepaid Expenses	-	-	0.8	0.2	0.4	0.7
Other Current Assets	-	5,803	5,506	5,394	5,433	4,537
Total Current Assets	-	19,263	21,187	17,839	16,976	18,670
Property, Plant & Equipment	-	21.8	26.1	13.3	14.6	21.5
Long-Term Investments	-	1,079	365.8	971.3	912.4	185.1
Goodwill	-	251.7	251.7	251.7	251.7	191.4
Other Intangible Assets	-	3.5	0.4	0.8	1.8	2.2
Long-Term Deferred Tax Assets	-	993.5	786.7	335.5	199.7	215.4
Other Long-Term Assets	-	148.4	118.3	326.1	314.6	394.3
Total Assets	-	21,761	22,736	19,738	18,671	19,680
Accounts Payable	-	32.5	52.2	25.2	45.1	167.1
Accrued Expenses	-	2	542	71.2	230.7	210.4
Short-Term Debt	-	-	9,129	6,482	11,564	12,327
Current Portion of Long-Term Debt	-	9,605	1,360	718.1	1,519	2,131
Current Portion of Leases	-	7.3	6.6	5.1	1.5	5.8
Other Current Liabilities	-	3,894	2,944	2,508	1,459	1,063
Total Current Liabilities	-	13,541	14,033	9,809	14,819	15,904
Long-Term Debt	-	9,436	8,656	8,668	2,182	2,256
Long-Term Leases	-	6	13.2	-	10	11.5
Other Long-Term Liabilities	-	395.6	378.6	377.5	376	375.4
Total Liabilities	-	23,378	23,092	18,866	17,396	18,554
Common Stock	-	75.7	75.7	75.7	75.7	75.7
Retained Earnings	-	-	-770.8	458.5	937.5	770.6
Comprehensive Income & Other	-	-1,693	338.3	337.6	261.4	278.7
Total Common Equity	-1,617	-1,617	-356.8	871.8	1,275	1,125
Minority Interest	-	-	-	-	-	0.3
Shareholders' Equity	-1,617	-1,617	-356.8	871.8	1,275	1,125
Total Liabilities & Equity	-	21,761	22,736	19,738	18,671	19,680
Total Debt	19,054	19,054	19,165	15,873	15,276	16,732
Net Cash (Debt)	-18,745	-18,745	-17,840	-15,395	-14,851	-15,692
Net Cash Per Share	-479.64	-495.36	-471.41	-406.79	-392.42	-560.82
Filing Date Shares Outstanding	42.84	37.85	37.84	37.84	37.84	27.94
Total Common Shares Outstanding	42.84	37.85	37.84	37.84	37.84	27.94
Working Capital	-	5,722	7,154	8,030	2,157	2,766
Book Value Per Share	-42.72	-42.72	-9.43	23.04	33.68	40.27
Tangible Book Value	-1,872	-1,872	-608.9	619.3	1,021	931.4
Tangible Book Value Per Share	-49.47	-49.47	-16.09	16.36	26.98	33.34
Land	-	-	0.5	0.5	0.5	0.5
Machinery	-	-	31.7	35.7	28.6	29.4

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.